CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 77 filers reported holding CASCADIAN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $82,000 | -9.9% | 22,193 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $91,000 | +11.0% | 22,193 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $82,000 | -10.9% | 22,193 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $92,000 | +58.6% | 22,193 | +65.1% | 0.00% | 0.0% |
| Q4 2016 | $58,000 | – | 13,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,000,000 | $12,420,000 | 3.14% |
| Abingworth LLP | 925,000 | $3,830,000 | 2.85% |
| BVF INC/IL | 3,133,224 | $12,972,000 | 2.21% |
| NEA Management Company, LLC | 9,064,575 | $37,527,000 | 1.30% |
| Anson Funds Management LP | 670,929 | $2,778,000 | 1.15% |
| Sandia Holdings, LLC | 543,719 | $2,251,000 | 1.13% |
| Redmile Group, LLC | 4,072,424 | $16,860,000 | 1.09% |
| Avoro Capital Advisors LLC | 1,821,248 | $7,540,000 | 0.96% |
| FT Options LLC | 143,429 | $594,000 | 0.78% |
| DAFNA Capital Management LLC | 185,259 | $767,000 | 0.65% |